↓ Skip to main content

Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study

Overview of attention for article published in Frontiers in Pharmacology, June 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (57th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
49 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study
Published in
Frontiers in Pharmacology, June 2022
DOI 10.3389/fphar.2022.883483
Pubmed ID
Authors

Asif Massud, Syed Azhar Syed Sulaiman, Nafees Ahmad, Muhammad Shafqat, Long Chiau Ming, Amer Hayat Khan

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 49 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 10%
Lecturer 4 8%
Student > Postgraduate 2 4%
Student > Ph. D. Student 1 2%
Other 1 2%
Other 2 4%
Unknown 34 69%
Readers by discipline Count As %
Medicine and Dentistry 6 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 10%
Arts and Humanities 1 2%
Nursing and Health Professions 1 2%
Biochemistry, Genetics and Molecular Biology 1 2%
Other 2 4%
Unknown 33 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2022.
All research outputs
#13,581,483
of 23,164,913 outputs
Outputs from Frontiers in Pharmacology
#4,108
of 16,557 outputs
Outputs of similar age
#183,593
of 443,272 outputs
Outputs of similar age from Frontiers in Pharmacology
#217
of 1,256 outputs
Altmetric has tracked 23,164,913 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 16,557 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,272 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.
We're also able to compare this research output to 1,256 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.